Discovery Rule Mesothelioma Claims

Discovery Rule for Mesothelioma Claims: Why You Can Sue Decades Later

Discovery Rule — Mesothelioma Claims
Doctrine	Discovery Rule (also called the "delayed-accrual" rule)
Effect	Statute of limitations starts at diagnosis, not exposure
Anchor case	Borel v. Fibreboard Paper Products Corp., 493 F.2d 1076 (5th Cir. 1973)
Applies in	All 50 states and Washington, D.C., in some form
Codified variations	California (Cal. Code Civ. Proc. §340.2), New York (CPLR §214-c), Connecticut (Conn. Gen. Stat. §52-577a)
Trigger	Diagnosis + knowledge (or constructive knowledge) of asbestos causation
Wrongful death	New clock starts at the date of death
State deadline range	1–6 years from diagnosis — see Statute_of_Limitations_by_State

The discovery rule is the legal doctrine that allows mesothelioma patients to file lawsuits decades after their original asbestos exposure. Instead of starting the statute of limitations clock on the date of last exposure — which, given mesothelioma's 20-to-50-year latency period, would bar virtually every claim before the patient knew they were sick — courts begin the clock at the date the patient is diagnosed with an asbestos-related disease and knows (or reasonably should know) that asbestos caused it.

A patient who worked with asbestos insulation in a shipyard in 1968 and is diagnosed with pleural mesothelioma in 2026 is not too late to sue. Under the discovery rule, the relevant date is 2026 — and the patient typically has 1 to 6 years from diagnosis to file, depending on the state. The doctrine traces to Borel v. Fibreboard Paper Products Corp., 493 F.2d 1076 (5th Cir. 1973) — the first federal appellate decision holding asbestos manufacturers strictly liable for failure to warn, and the case that crystallized the principle that workers could not have known of the danger during their working years.

For your state's specific filing deadline, see Statute of Limitations by State. This page explains the doctrine itself: why it exists, how courts apply it, what triggers the clock, and how it interacts with trust-fund claims, wrongful-death claims, and misdiagnosis scenarios.

Key Facts: Discovery Rule for Mesothelioma

Fact	Detail
Date the statute of limitations clock starts	Date of diagnosis (in most states), not date of exposure
Average mesothelioma latency from first exposure to diagnosis	20–50 years (median ~32–34 years)
States applying the discovery rule (some form)	All 50 + D.C.
Codified discovery-rule statutes	California (Cal. Code Civ. Proc. §340.2), New York (CPLR §214-c), Connecticut (Conn. Gen. Stat. §52-577a)
Common-law discovery rule states (judge-made)	Most other states (e.g., Texas, Illinois, Pennsylvania, Ohio, Florida)
1-year filing window after diagnosis	California, Kentucky, Louisiana, Tennessee
Longest filing windows (5–6 years from diagnosis)	Maine, Minnesota, North Dakota, Missouri (pending reduction)
Foundational asbestos case	Borel v. Fibreboard Paper Products Corp., 493 F.2d 1076 (5th Cir. 1973)
Wrongful-death clock	Restarts at the date of death; 1–3 years to file in most states
Patients past their state's SOL when they first contact a mesothelioma firm	~33% — the most-cited reason for the urgency of early consultation

What Is the Discovery Rule?

The discovery rule is a common-law and statutory doctrine that delays the start of the statute of limitations until the date a plaintiff knew, or by reasonable diligence should have known, of an injury caused by the defendant's conduct. In asbestos litigation, "injury" means a diagnosed asbestos-related disease — mesothelioma, asbestosis, asbestos-related lung cancer, or pleural plaques with impairment — and "cause" means exposure attributable to a specific manufacturer's product, employer's premises, or military service location.

Without the discovery rule, the statute of limitations would begin at the date of last asbestos exposure — typically the 1960s, 1970s, or 1980s for a current mesothelioma plaintiff. The typical 2-year or 3-year statute would expire 20 to 50 years before the patient experienced any symptom, time-barring every claim. The discovery rule corrects this by recognizing that the law's purpose is not to punish plaintiffs for the latency of their injury. The statute of limitations is meant to prevent plaintiffs from sleeping on known claims — an interest with no application when the plaintiff could not have known of the claim until decades after the wrongful act. The doctrine is sometimes called the "delayed-accrual rule" in academic literature. In codified form (California's §340.2 is the cleanest example), it appears in state civil procedure codes as a specific exception for asbestos and similar long-latency toxic torts.

How Mesothelioma's Latency Period Made the Discovery Rule Essential

Mesothelioma is the prototype long-latency disease. The interval between first asbestos exposure and clinical diagnosis is rarely shorter than 20 years and is most commonly 30 to 50 years; the U.S. registry median is 32–34 years. Asbestos fibers inhaled at the workplace lodge in the pleura or peritoneum and produce no immediate symptoms; over decades they drive chronic inflammation and eventually neoplastic transformation. By the time symptoms appear, the patient is decades removed from the exposure that caused them.

The legal consequence is direct: a strict exposure-based SOL would void every mesothelioma claim. A worker exposed in 1972 at age 25 who develops symptoms in 2027 at age 80 would be 53 years late under a 2-year exposure rule. Courts recognized this absurdity early; by the late 1960s, state and federal courts had begun applying discovery-rule reasoning to long-latency occupational diseases. Borel v. Fibreboard (1973) crystallized the principle for asbestos. State courts and legislatures followed in waves throughout the 1970s and 1980s, codifying or judicially adopting variants of the rule specifically for asbestos diseases. See Mesothelioma_Diagnosis and Mesothelioma_Latency_Period for the clinical course.

Origins: Borel v. Fibreboard Paper Products Corp. (5th Cir. 1973)

Clarence Borel v. Fibreboard Paper Products Corp., 493 F.2d 1076 (5th Cir. 1973), is the foundational case in U.S. asbestos litigation. Clarence Borel was an insulator who worked from 1936 to 1969 installing asbestos thermal insulation across the Gulf Coast. Diagnosed with asbestosis in 1969 and mesothelioma shortly before his death in 1970, his estate sued six asbestos manufacturers — Fibreboard, Johns-Manville, Owens-Corning Fiberglas, Pittsburgh Corning, Standard Asbestos, and Ruberoid — for strict products liability and failure to warn.

The Fifth Circuit affirmed the jury verdict for Borel's estate, holding that asbestos manufacturers owed end-user workers a direct duty to warn that was not discharged merely by warning the worker's employer. Borel was the first federal appellate decision to apply strict products liability to industrial asbestos products, and it opened the wave of asbestos litigation that continues today.

Borel is not itself a statute-of-limitations decision — its relevance to the discovery rule is conceptual. The opinion's factual record documented the disparity between the medical literature available to manufacturers (who knew of asbestos disease risks by the 1930s) and the warnings actually provided to workers (essentially none). This finding — that workers could not have known — became the foundational pillar of discovery-rule arguments in subsequent state and federal asbestos cases. If workers had no reason to suspect harm during exposure, equitable principles require that the statute of limitations not begin until they actually discover (or should have discovered) the injury. The conceptual anchor for the modern asbestos discovery rule runs back to the Borel trial record.

Three Variations of the Discovery Rule Across States

All 50 states apply some form of the discovery rule to asbestos claims, but operational details vary. The variations fall into three groups.

1. Common-Law Diagnosis Standard (Most States)

In roughly 47 states and the District of Columbia, the discovery rule is a judicially adopted common-law doctrine. The clock starts when the plaintiff is diagnosed with an asbestos-related disease and knows (or reasonably should know) that asbestos caused it. The exact statutory deadline (1 to 6 years) varies by state, but the trigger — diagnosis-plus-knowledge — is consistent. Pennsylvania additionally recognizes the separate disease rule (a later mesothelioma diagnosis starts a new clock independent of an earlier asbestosis diagnosis).

2. California's Codified Disability Standard (Cal. Code Civ. Proc. §340.2)

California is the most notable codified outlier. Cal. Code Civ. Proc. §340.2 specifies a 1-year window from the later of two events: (a) the date the plaintiff suffered "disability" — loss of ability to engage in regular employment because of the asbestos-related disease, or (b) the date the plaintiff knew (or with reasonable diligence should have known) the disability was asbestos-caused.

The disability standard can be more plaintiff-friendly than a pure diagnosis standard: a worker diagnosed with asbestos-related pleural plaques in 2015 may not become disabled until pleural mesothelioma manifests in 2024, and the California clock does not start until 2024. California's wrongful-death deadline is also 1 year, running from the date of death.

3. New York's Codified Discovery Rule (CPLR §214-c)

New York's discovery rule for "latent effects of exposure to any substance" is codified at CPLR §214-c. The 3-year personal-injury clock begins on "the date of discovery of the injury by the plaintiff or … the date when through the exercise of reasonable diligence such injury should have been discovered."

Pawlowski v. Asbestos Defendants (N.Y. Sup. Ct. 2024) is the leading recent application. The court held that isolated or inconsequential symptoms — such as discovery of a small abdominal nodule years before a full peritoneal mesothelioma diagnosis — do not trigger CPLR §214-c. The clock starts only on discovery of "manifestations or symptoms of the latent disease that the harmful substance produced."

Connecticut's Codified Variation (Conn. Gen. Stat. §52-577a)

Connecticut codifies a discovery-rule variant at Conn. Gen. Stat. §52-577a for product liability claims involving asbestos and similar long-latency injuries: a 3-year window from discovery, with a separate 10-year statute of repose measured from the act or omission complained of. Connecticut courts have applied §52-577a flexibly to asbestos cases to avoid repose defenses where latency is established.

For your state's specific filing window, see Statute_of_Limitations_by_State, updated to reflect 2025 tort-reform changes including Missouri HB 68, Arkansas HB 1204, Georgia SB 68, and Florida's 2023 reduction from 4 years to 2 years.

What Triggers the Statute of Limitations Clock?

Two conditions must be satisfied: (1) the plaintiff is diagnosed with an asbestos-related disease, and (2) the plaintiff knows or reasonably should know that asbestos caused it. For mesothelioma, both prongs are usually satisfied simultaneously at diagnosis because mesothelioma is so strongly associated with asbestos that diagnosis effectively implies awareness of the cause.

A formal medical diagnosis is required — mesothelioma (pleural, peritoneal, pericardial, or tunica vaginalis testis variants, confirmed by tissue biopsy and immunohistochemistry), asbestos-related lung cancer, asbestosis, or in some states pleural plaques with functional impairment. Casual or preliminary findings — a nodule on an incidental CT scan, a borderline lab value, a not-yet-worked-up symptom — do not start the clock. Pawlowski confirmed under CPLR §214-c that isolated or inconsequential findings are not the "injury" the latency-disease discovery rule contemplates.

For mesothelioma the causation prong is almost always presumed at diagnosis. For other diseases — particularly lung cancer in a worker with mixed exposure history (asbestos plus smoking) — causation can be litigated; the clock starts when the plaintiff should reasonably have made the causal connection. When a patient is initially misdiagnosed with a different disease and the correct mesothelioma diagnosis is made later, the clock begins at the corrected-diagnosis date. If mesothelioma is identified only at autopsy, the wrongful-death clock starts at death, and survival actions may relate back to the autopsy diagnosis depending on state law.

The "Should Have Known" Standard

The discovery rule's causation prong contains an objective component: the clock starts not only when the plaintiff actually knows of asbestos causation, but when the plaintiff reasonably should have known through ordinary diligence. This element is the doctrine's gatekeeper against indefinite tolling — but courts have consistently found that mesothelioma patients had no obligation to investigate asbestos causation before diagnosis. Workers exposed in the 1960s, 1970s, and 1980s had no reason to suspect injury during exposure: asbestos products were marketed as safe; warnings were absent or grossly inadequate; manufacturers actively suppressed disease-risk information (see corporate asbestos coverup).

The burden of proving constructive knowledge under the "should have known" standard rests on the defendant. Vague exposure rumors are not enough; isolated press reports are not enough; even general awareness that "asbestos can be dangerous" is not enough without specific knowledge tying the plaintiff's exposure to a specific product and a specific disease. As a result, mesothelioma defendants rarely prevail on "should have known" arguments. Most successful SOL dismissals occur in cases of clear post-diagnosis delay — a patient correctly diagnosed in 2020, told by a doctor that asbestos caused it, then waiting until 2025 to file in a 2-year state. Cases of long pre-diagnosis exposure followed by recent diagnosis almost always survive SOL challenges.

Fraudulent Concealment Doctrine

When an asbestos manufacturer, employer, or premises owner actively concealed the dangers of asbestos from workers and the public, the doctrine of fraudulent concealment independently tolls the statute of limitations until the concealment is discovered. This is separate from the discovery rule but often operates alongside it.

The asbestos industry's concealment of disease risks is one of the most extensively documented corporate-coverup records in U.S. legal history. Internal memoranda from Johns-Manville, Owens-Corning, Raybestos-Manhattan, and other major manufacturers from the 1930s through the 1970s show that company medical departments knew of the asbestos-lung disease link decades before workers were warned. Industry-funded research minimized risks; trade associations coordinated suppression of scientific findings. California, New Jersey, New York, and Texas courts have all applied fraudulent-concealment tolling in asbestos cases. The recent New Jersey decision Dondero v. Abdelhak (App. Div., March 2025), though not itself an asbestos case, has been cited in asbestos motion practice for the principle that nonparties acting in concert with concealing defendants can be liable under civil-conspiracy theories. The practical effect: even in short-SOL states, plaintiffs can argue that fraudulent concealment tolled the clock until the concealment was discovered.

Trust Fund Claims vs. Lawsuits: Different Discovery Rule Rules

Asbestos trust fund claims have administrative deadlines separate from — and often shorter than — state-law statutes of limitations for lawsuits. Many mesothelioma claimants pursue both: a lawsuit against solvent defendants and trust-fund claims against the bankruptcy trusts of defunct manufacturers. The two paths run on different clocks.

Asbestos trust funds are administrative claims facilities created when major asbestos manufacturers reorganized under §524(g) of the Bankruptcy Code. Over 60 trusts hold $30+ billion in committed assets. Each trust publishes a Trust Distribution Procedure (TDP) governing eligibility, documentation, and filing deadlines — typically 3 years from diagnosis. Three principles govern the trust/lawsuit relationship: (1) Trust-fund deadlines are not state SOLs — missing a TDP deadline does not bar a lawsuit; missing a state SOL does. (2) Filing a trust claim does not toll the lawsuit SOL — the state-law clock continues to run. (3) Trust-fund settlements do not preclude lawsuits — plaintiffs can still sue solvent defendants for portions of the injury attributable to their products.

The practical implication: a newly diagnosed patient should investigate both trust-fund eligibility and lawsuit viability promptly. Filing only trust claims while ignoring the lawsuit SOL can lose 50–80% of recoverable compensation. The standard mesothelioma compensation strategy combines trust claims (typically 10–20 trusts) with active litigation against 5–25 solvent defendants. See Mesothelioma_Claim_Process.

Wrongful Death Claims: When the Clock Restarts

When a mesothelioma patient dies before filing or before resolving a personal-injury claim, a new statute of limitations clock starts for the family's wrongful-death action. The wrongful-death clock begins on the date of death, regardless of when the personal-injury clock would have expired. Family members have 1 to 3 years from the date of death in most states.

This clock-restart exists because wrongful death is a separate cause of action — the plaintiff is a surviving family member (typically a spouse, child, or parent), not the decedent, and the injury is the death itself. The cause of action cannot accrue before the death because it does not exist before the death. For the state-by-state wrongful-death window, see Statute_of_Limitations_by_State.

A critical asymmetry: several states have wrongful-death deadlines shorter than the personal-injury deadlines applicable while the patient was alive. In Maine, a living patient has 6 years to file personal-injury claims, but the family has only 2 years after death. North Dakota and Minnesota follow similar patterns. Families in these jurisdictions can lose the wrongful-death claim entirely by delaying after death — even by a delay that would have been acceptable while the patient was alive. For wrongful-death rules, eligible plaintiffs, recoverable damages, and the survival-action interaction, see Wrongful_Death_Claims.

Misdiagnosis and the Discovery Rule

Mesothelioma is sometimes misdiagnosed as lung cancer, adenocarcinoma, pleural effusion of unknown origin, or sarcoidosis before the correct diagnosis is made. The SOL clock begins on the date of the corrected mesothelioma diagnosis, not the original misdiagnosis. Initial lung-cancer or pleural-effusion diagnoses do not start the clock; the corrected biopsy-confirmed mesothelioma diagnosis does. For decedents whose mesothelioma is identified only at autopsy, survival actions start at the autopsy diagnosis and wrongful-death actions at the date of death.

Pawlowski v. Asbestos Defendants (N.Y. Sup. Ct. 2024) is the leading recent decision: the court declined to start the SOL clock at the 2017 surgical removal of a small abdominal nodule because that finding, in isolation, was not "the latent disease" within CPLR §214-c. The full peritoneal mesothelioma diagnosis came later, and the clock started then. Patients with complex diagnostic timelines should preserve all pathology reports, treating-physician notes, imaging studies, and biopsy slides — the corrected-diagnosis date is the legally significant SOL start.

The Separate Disease Rule

A small number of states recognize the separate disease rule — each distinct asbestos-related disease starts its own SOL clock. A patient diagnosed with asbestosis in 2008 can file an asbestosis claim within the state's SOL, then file a separate mesothelioma claim if mesothelioma develops in 2026, even if the original asbestosis SOL has long expired. Pennsylvania is the leading separate-disease jurisdiction; the Pennsylvania Supreme Court affirmed the rule in Abrams v. Pneumo Abex Corp., 602 Pa. 627 (2009). California, New Jersey, and several other states have applied separate-disease analysis in specific contexts, though less uniformly than in Pennsylvania.

The rule does not apply nationwide. In states without it, patients who file early asbestosis claims risk having later mesothelioma claims treated as continuations of the original injury — potentially time-barred under the asbestosis SOL. Plaintiff counsel in non-separate-disease states typically advise against early filing for non-malignant asbestos disease precisely to preserve later mesothelioma claims.

Government Claim Exceptions

Asbestos exposure at federal government facilities (military bases, VA hospitals, federal shipyards, federal office buildings) is governed by the Federal Tort Claims Act, 28 U.S.C. § 2401(b), which imposes its own procedural deadlines: a 2-year administrative-claim deadline from injury or discovery, plus a 6-month deadline to file suit after agency denial. Claims must exhaust the administrative process first. The FTCA's discovery-rule analog applies under federal law, but the compressed procedural window makes prompt action essential.

The Feres doctrine bars military service members from suing the U.S. military for service-connected injuries. Asbestos-exposed veterans cannot sue the military itself but retain the right to sue private manufacturers, file VA disability claims (no SOL), and file trust-fund claims. State and local government claims (public schools, municipal buildings, state-operated facilities) are governed by state tort claims acts with separate notice and filing deadlines — typically 30-to-180-day notice requirements and 1-to-2-year filing windows. The discovery rule still applies, but the post-diagnosis window can be very short.

Frequently Asked Questions

Can I sue for asbestos exposure that happened 30 or 40 years ago?

Yes — in nearly all U.S. states, you can sue for mesothelioma decades after the original asbestos exposure. The discovery rule, adopted in some form by all 50 states and D.C., starts the clock at the date of diagnosis (and knowledge of asbestos causation) — not at the date of exposure. Because mesothelioma has a 20-to-50-year latency period, this rule is essential. Without it, every mesothelioma claim would be time-barred before the patient knew they were sick.

The doctrine traces to Borel v. Fibreboard Paper Products Corp., 493 F.2d 1076 (5th Cir. 1973), which established that workers exposed in the 1930s through 1960s could not have known of asbestos dangers during their working years. Today, the typical mesothelioma plaintiff has the full state-law window — 1 to 6 years from diagnosis — to file suit, regardless of how long ago the exposure occurred. Approximately one-third of patients who contact mesothelioma firms are already past their state's SOL because they delayed too long after diagnosis, so prompt consultation matters. For your state's deadline, see Statute_of_Limitations_by_State.

What is the statute of limitations for filing a mesothelioma lawsuit?

The statute of limitations for a mesothelioma personal-injury lawsuit ranges from 1 to 6 years from diagnosis, depending on the state. The most common deadline is 2 years (about 25 states). Four states impose 1 year (California, Kentucky, Louisiana, Tennessee); Maine, Minnesota, and North Dakota allow 6; Missouri allows 5 (with House Bill 68 proposing reduction to 2). The clock starts when the patient is diagnosed and knows (or reasonably should know) that asbestos caused the disease — typically the diagnosis date itself for mesothelioma.

Wrongful-death claims follow a separate clock running 1 to 3 years from the date of death. In Maine, North Dakota, and Minnesota, the wrongful-death window is substantially shorter than the personal-injury window — a critical asymmetry for surviving families. Asbestos trust fund claims run on a third set of clocks set by each trust's Trust Distribution Procedure (typically 3 years from diagnosis). For your state's exact deadline, see Statute_of_Limitations_by_State.

Does filing a VA disability claim affect the lawsuit statute of limitations?

No. Filing a VA disability claim does not affect the lawsuit SOL. The two systems are independent. VA disability benefits for service-connected asbestos disease have no statute of limitations (though earlier filing means earlier benefits). A separate lawsuit against private asbestos manufacturers — the companies whose products caused exposure during military service — follows the state-law discovery rule and is not tolled by VA filing. Veterans typically pursue all three paths in parallel: VA disability, asbestos trust fund claims, and private-defendant lawsuits. See Veterans_Benefits.

Does filing an asbestos trust fund claim toll the lawsuit statute of limitations?

No. Filing a trust fund claim does not toll the lawsuit SOL. The state-law clock for the lawsuit against solvent defendants continues to run independently. A plaintiff who files only trust claims — without separately preserving the lawsuit by timely court filing — can lose the lawsuit portion of the recovery (typically 50–80% of total compensation). Trust funds are administrative facilities under §524(g) of the Bankruptcy Code; their deadlines are contractual TDP provisions, not state-law statutes. Counsel typically files lawsuits and trust claims in parallel. See Mesothelioma_Claim_Process and Asbestos_Trust_Funds.

What if I was misdiagnosed with another cancer first?

The discovery rule's clock starts at the date of the corrected mesothelioma diagnosis, not the original misdiagnosis. Courts have consistently held that a patient initially misdiagnosed with lung cancer, sarcoidosis, idiopathic pleural effusion, or another condition does not have actionable mesothelioma knowledge until the corrected diagnosis is made. Pawlowski v. Asbestos Defendants (N.Y. Sup. Ct. 2024) confirmed under CPLR §214-c that isolated or inconsequential findings — such as discovery of a small nodule years before a full peritoneal mesothelioma diagnosis — do not trigger the SOL. Patients with complex diagnostic timelines should preserve all medical records because the corrected-diagnosis date becomes legally significant.

Can my family sue if I die before filing a mesothelioma lawsuit?

Yes. If a patient dies before filing, surviving family members have a separate wrongful-death cause of action with a new clock starting at the date of death — typically 1 to 3 years. Eligible plaintiffs vary by state but usually include the spouse, children, and (in some states) parents. Recoverable damages include economic losses and, in most states, non-economic losses such as loss of companionship and grief. New York is a notable exception, allowing only economic damages in wrongful-death actions; the "Grieving Families Act" that would have changed this was vetoed for the third time by Governor Hochul in 2025. Patients with active mesothelioma should consider filing the personal-injury lawsuit while alive, converting to survival action plus wrongful-death claim if death intervenes — this approach maximizes recovery and avoids the shorter wrongful-death windows in Maine, North Dakota, and Minnesota. See Wrongful_Death_Claims.

Quick Statistics: Discovery Rule in Practice

Statistic	Value
Average mesothelioma latency (first exposure → diagnosis)	20–50 years; median ~32–34 years
Approximate share of mesothelioma patients who contact a firm past their state SOL	~33% — the most common SOL pitfall
States with 1-year personal-injury SOL	4 (California, Kentucky, Louisiana, Tennessee)
States with 6-year personal-injury SOL	3 (Maine, Minnesota, North Dakota)
Average asbestos trust fund TDP filing deadline	3 years from diagnosis (varies by trust)
Number of active asbestos bankruptcy trusts	60+
Combined trust-fund assets available for compensation	$30+ billion
Average mesothelioma lawsuit settlement	$1 million – $1.4 million
Average mesothelioma trial verdict	$5 million – $11.4 million
Foundational case crystallizing manufacturer liability	Borel v. Fibreboard, 493 F.2d 1076 (5th Cir. 1973)

Get Help: Talk to a Mesothelioma Attorney Promptly

The most common reason a mesothelioma patient or family loses their right to compensation is delay — waiting too long after diagnosis to consult an attorney. Case-building takes months: identifying exposure sites, locating co-workers, obtaining employment records, ordering pathology slides, and preparing trust-fund packages. Filing close to the SOL deadline risks rushed work and missed opportunities.

The discovery rule is the patient's friend — but the post-diagnosis window is the patient's deadline. Danziger & De Llano handles mesothelioma and asbestos cases nationwide and offers free case evaluations: call (855) 699-5441 or visit dandell.com/contact-us.

⚠ Statute of Limitations Warning: Filing deadlines vary by state from 1-6 years from diagnosis. Texas allows 2 years from diagnosis or discovery. Contact an attorney immediately to preserve your rights.

See Also

• Statute of Limitations by State — 50-state filing deadlines
• Mesothelioma Lawsuits — overview of personal-injury and product-liability claims
• Asbestos Trust Funds — $30+ billion in active trusts
• Trust Fund Filing Guidance
• Mesothelioma Claim Process — integrated lawsuit + trust-fund workflow
• Wrongful Death Claims — survival actions and wrongful-death rules
• Mesothelioma Diagnosis — clinical workup that starts the SOL clock
• Corporate Asbestos Coverup — factual basis for fraudulent-concealment tolling
• Veterans Benefits — VA disability claims (no statute of limitations)
• Federal Tort Claims Act — federal-facility exposure rules